Formycon (ETR:FYB) H1 2024 results Key financial results Sales: €26.9 million (39% less than in the first half of 2023). Net loss: €10.1 million (compared to €1.80 million profit in the first half of 2023). €0.58 loss per share (after €0.11 profit in the first half of 2023). Profit and sales growth All figures shown […]